Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $14.26 billion. The enterprise value is $13.56 billion.
Market Cap | 14.26B |
Enterprise Value | 13.56B |
Important Dates
The last earnings date was Wednesday, May 1, 2024, before market open.
Earnings Date | May 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NBIX has 100.64 million shares outstanding. The number of shares has increased by 6.69% in one year.
Shares Outstanding | 100.64M |
Shares Change (YoY) | +6.69% |
Shares Change (QoQ) | +1.37% |
Owned by Insiders (%) | 1.00% |
Owned by Institutions (%) | 95.97% |
Float | 99.42M |
Valuation Ratios
The trailing PE ratio is 38.81 and the forward PE ratio is 29.90. NBIX's PEG ratio is 0.44.
PE Ratio | 38.81 |
Forward PE | 29.90 |
PS Ratio | 7.19 |
Forward PS | 6.18 |
PB Ratio | 5.97 |
P/FCF Ratio | 23.20 |
PEG Ratio | 0.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.28, with an EV/FCF ratio of 22.06.
EV / Earnings | 36.67 |
EV / Sales | 6.84 |
EV / EBITDA | 27.28 |
EV / EBIT | 28.57 |
EV / FCF | 22.06 |
Financial Position
The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.21.
Current Ratio | 2.52 |
Quick Ratio | 2.33 |
Debt / Equity | 0.21 |
Debt / EBITDA | 1.03 |
Debt / FCF | 0.83 |
Interest Coverage | 103.15 |
Financial Efficiency
Return on equity (ROE) is 17.50% and return on invested capital (ROIC) is 12.61%.
Return on Equity (ROE) | 17.50% |
Return on Assets (ROA) | 12.10% |
Return on Capital (ROIC) | 12.61% |
Revenue Per Employee | $1.42M |
Profits Per Employee | $264,071 |
Employee Count | 1,400 |
Asset Turnover | 0.65 |
Inventory Turnover | 1.10 |
Taxes
In the past 12 months, NBIX has paid $100.20 million in taxes.
Income Tax | 100.20M |
Effective Tax Rate | 21.32% |
Stock Price Statistics
The stock price has increased by +51.50% in the last 52 weeks. The beta is 0.28, so NBIX's price volatility has been lower than the market average.
Beta (1Y) | 0.28 |
52-Week Price Change | +51.50% |
50-Day Moving Average | 138.64 |
200-Day Moving Average | 124.62 |
Relative Strength Index (RSI) | 55.55 |
Average Volume (30 Days) | 845,993 |
Short Selling Information
The latest short interest is 1.83 million, so 1.82% of the outstanding shares have been sold short.
Short Interest | 1.83M |
Short Previous Month | 2.02M |
Short % of Shares Out | 1.82% |
Short % of Float | 1.84% |
Short Ratio (days to cover) | 2.37 |
Income Statement
In the last 12 months, NBIX had revenue of $1.98 billion and earned $369.70 million in profits. Earnings per share was $3.65.
Revenue | 1.98B |
Gross Profit | 1.94B |
Operating Income | 464.40M |
Pretax Income | 469.90M |
Net Income | 369.70M |
EBITDA | 497.00M |
EBIT | 474.50M |
Earnings Per Share (EPS) | $3.65 |
Balance Sheet
The company has $1.21 billion in cash and $511.90 million in debt, giving a net cash position of $698.70 million or $6.94 per share.
Cash & Cash Equivalents | 1.21B |
Total Debt | 511.90M |
Net Cash | 698.70M |
Net Cash Per Share | $6.94 |
Equity / Book Value | 2.39B |
Book Value Per Share | 23.71 |
Working Capital | 1.09B |
Cash Flow
In the last 12 months, operating cash flow was $645.40 million and capital expenditures -$31.00 million, giving a free cash flow of $614.40 million.
Operating Cash Flow | 645.40M |
Capital Expenditures | -31.00M |
Free Cash Flow | 614.40M |
FCF Per Share | $6.16 |
Margins
Gross margin is 98.05%, with operating and profit margins of 23.43% and 18.65%.
Gross Margin | 98.05% |
Operating Margin | 23.43% |
Pretax Margin | 23.71% |
Profit Margin | 18.65% |
EBITDA Margin | 25.08% |
EBIT Margin | 23.94% |
FCF Margin | 31.00% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.69% |
Shareholder Yield | -6.69% |
Earnings Yield | 2.59% |
FCF Yield | 4.31% |
Analyst Forecast
The average price target for NBIX is $150.18, which is 6.02% higher than the current price. The consensus rating is "Buy".
Price Target | $150.18 |
Price Target Difference | 6.02% |
Analyst Consensus | Buy |
Analyst Count | 23 |
Revenue Growth Forecast (5Y) | 15.52% |
EPS Growth Forecast (5Y) | 42.06% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 9.22 and a Piotroski F-Score of 5.
Altman Z-Score | 9.22 |
Piotroski F-Score | 5 |